Cargando…
Translating the biology of aging into novel therapeutics for Alzheimer disease
Aging is the leading risk factor for most chronic illnesses of old age, including Alzheimer disease (AD), a progressive neurodegenerative disease with currently no therapies that prevent, slow, or halt disease progression. Like other chronic diseases of old age, the progressive pathology of AD begin...
Autores principales: | Hara, Yuko, McKeehan, Nicholas, Fillit, Howard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340342/ https://www.ncbi.nlm.nih.gov/pubmed/30530798 http://dx.doi.org/10.1212/WNL.0000000000006745 |
Ejemplares similares
-
Value-Generating Exploratory Trials in Neurodegenerative Dementias
por: Friedman, Lauren G., et al.
Publicado: (2021) -
Splicing therapeutics for Alzheimer's disease
por: Wasser, Catherine R, et al.
Publicado: (2016) -
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis
por: Ferreira, Daniel, et al.
Publicado: (2020) -
Peripheral biomarkers of oxidative stress in aging and Alzheimer’s
disease
por: Marcourakis, Tania, et al.
Publicado: (2008) -
Palm OS programming: the developer's guide
por: Rhodes, Neil, et al.
Publicado: (2002)